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Abstract
The amine-carboxyboranes and related derivatives have been shown to be
potent anti-inflammatory and anti-osteoporosis agents. Their action in
part appears to be mediated by the modulation of cytokines, e.g. TNF
or IL-I. Previous studies have demonstrated that LPS induced
macrophages release of TNF maximally at 60 to 90 min. and IL-I from 5
to 8 hr. The amine-carboxyboranes reduced significantly the release of
these cytokines but also blocked TNF high affinity binding to UMR-106
receptor at 90 min. at i0 M, and IL-I high affinity binding at 5 hr. at
12.5 M. In addition, the agents suppressed IL-8 binding to CHO K1 high
affinity receptor at 24 hr. at 50 M and IL-2 binding to HUT-8 receptors
at 25 M at 90 min. and 5 hr. Correlation of metabolic events
associated with osteoporosis showed that at 90 min., when TNF receptor
binding was reduced by the agents, calcium uptake into UMR-106 cells was
reduced at i0 M as well as the acid and alkaline phosphatases, and the
prostaglandin cyclo-oxygenase activities and adhesion of leukocytes and
macrophages to UMR-106 cell monolayers. At 5hr. when the agents reduced
IL-I binding to UMR-106 receptors, calcitonin and 1,25-dihydrovitamin D3
binding was reduced by the agents as was acid and alkaline phosphatase,
and 5’-lipoxygenase activities and white blood cell adhesion. At this
time calcium uptake and proline incorporation was increased
significantly by the agents. At later times e.g. 18-48 hr. calcium
uptake was still increased, and NAG activity was inhibited in the
presence of the agents. These effects may be related more to the
inhibition of other cytokine receptor binding, e.g. IL-8. Thus, many of
the observed metabolic effects of amine-carboxyboranes as anti-
osteoporosis agents can be correlated with their inhibition of cytokine
high affinity binding to target cell receptors.
Introduction
Selected amine-carboxyborane derivatives at 8 mg/kg/day have been shown
to prevent osteoporosis and loss of bone mass in rodents[l]. In vitro
studies with CF1 mouse pups calvaria and rat UMR-106 osteosarcoma cells
have shown that these compounds over 48 hr. reduce the loss of calcium
from the cells better than calcitonin and simple boron salts[l].
Indications from the previous in vivo and in vitro studies were that the
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amine-carboxyboranes effectively lowered TNF and IL-I release from
macrophages[l,2] which is asociated with a lowering of hydrolytic and
proteolytic enzyme activities and secondary chemical effects from
prostaglandins and leukotirenes released at the sites of
inflammation[3,4] and of bone osteoporosis[l] The previous studies did
not attempt to correlate the incubation time of the drugs with the
maximum released of the cytokines into the medium. The present study
has been performed in rat UMR-106 bone cells at times, i.e. 90 min. and
5 hr., which have been shown to be the time periods of maximum release
of cytokines, TNF and IL-I, from macrophages. These time points were
selected so that we can determine the direct effect of those cytokines
on specific biochemical events of bone metabolism. The selected
compounds at 8 mg/kg/day orally have been shown in vivo in lactating
ovariectomized rats to significantly elevate femur and humerus volume,
weight, density and ash weight after 14 days[l]. Also, serum calcium
and femur calcium levels were elevated whereas hydroxyproline levels
were reduced in rodents by the amine-carboxyboranes.
Methods and Materials
The amine-carboxyborane derivatives were previously synthesized and the
chemical and physical characteristics reported i] Compound 1
(C6H5 3PBH2COOH, Compound 2_ CI6H33N (CH3 2BH2COOH and Compound 3
(CH3) 3NBH2COOCH3 TNF, IL-I, IL-2, IL-8 and the standards were
purchased from Sigma Chemical Co.
Cell Maintenance
Rat UMR-106 osteosarcoma clls (DMEM + 10% fetal calf serum (FCS) +
penicillin/streptomycin [P/S]) and IC-21 mouse macrophages (RPMI 1640 +
10% FCS + P/S) were grown to confluency[l]. Mouse macrophages (J774 A)
were maintained in DMEM + 15% FCS + P/S; human peripheral leukocytes
(RPMI 1788) were maintained in RPMI 1640 + 15% FC$ + P/S. Chinese
hamster ovaian (CHO) K1 cells were maintained in EMEM + 10% FC$ +
nonessential amino acids + P/$. HUT-8 cells human cutaneous T cell
lymphoma were maintained in RPMI + 10% FCS + gentamycin/kanamycin.
High Affinity Binding to Receptors on UMR-106 Cells
Two MCi of 125I-TNF (human recombinant 30 mCi/g New England Nuclear)
or 125I-IL-I (70-120 Ci/g,New England Nuclear) was added to confluent
UMR-106 cells for 30 to 120 min with the amine-carboxyboranes from I0 to
50 M [5]. 125IL-8 [2Ci/mol, Amersham] was added to confluent CHO K1
cells for 5 to 24 hr. and 125IL-2 [20-50 Ci/ug, New England Nuclear]
was added to confluent HUT-8 cells from 5 to 48 hr with drugs. All of
these cells have high affinity receptor within their plasma membrane for
the specific cytokine. After the allotted time period, the medium was
decanted gently and the cells were washed 6 X in cold isotonic PBS, pH
7.2. The cells were taken up in 0.1N NaOH and aliquots were counted.
125I-Calitonin (human, 2000 Ci/nmole, Amersham) or 3H-I, 25-dihyr-
oxyvitamine D.: (155-175 Ci/mmole, New England Nuclear) i0 Ci were added
to confluent UMR-106 cells with drugs from i0 to i00 M and incubated 90
min. or 5 hr. Cells were washed repeatedly in PBS and take-up in 0.i N
NaOH. In the case of 1,25-dihydro-vitamin D3a
the nuclei preparation was
obtained. The aliquots were counted in a P hard Beta counter corrected
for quenching, and non-specific binding of isotopes.
45Ca Uptake and 3H Proline Incorporation into Collagen of UMR-106 Cells
45CAC12 (0.2 mCi, New England Nuclear) was added to confluent UMR 106,
The medium was decanted and the cells were washed 4 times with PB$, pH
32M.E. Murphy, A.L. Elkins, R.P. Shrewsbury
A. Sood, B.F. Spielvogel and LH. Hall
Metal-BasedDrugs
7.2 [6,7]. The cells were taken up in 0.1N NaOH and counted [24,25].
Rat UMR-106 cells (95% confluent) were incubated with 1 Ci of 2,3,4,5-
3H-proline (102 Ci/mmol., New England Nuclear) and drugs. After 24 hr,
the medium was discarded and the cells were washed repeatedly with PBS.
The cells were harvested in 0.1N NaOH. After treatment with 20% TCA,
cells were centrifuged at 3500 g X 5 min. The supernatant was discarded
and the pellet was suspended in 1 ml of 50 mM Tris + 5 mM CaCI2 + 20 i
of collagenase (i0 mg/ml buffer, Sigma Chemical Co. [St. Louis, MO]) and
incubated for 2 hr at 37C. Tannic acid:TCA (5%) [i:i] solution was
added and incubated for 15 min at room temperature followed by
centrifugation to separate the collagen from non-collagen protein[8].
Lysosomal Enzymes
UMR-106 cells [108 were grown to confluency and incubated for 90 min.
or 5 hr. with drugs at 12.5, 50 and i00 M. Acid and alkaline
phosphatase activities were determined using 0.i M -glycerolphosphate
in 0.I M acetate buffer, pH 5.0 and 8.5, respectively[l-3] Total
enzyme was released with Triton X-100. The reaction was terminated with
10% TCA and then the solution was centrifuged at 3500 g for I0 min. The
inorganic phosphate in the supernatant was determined
spectrophotometrically at 800 nm by the method of Chen et al. [9]. N-
Acetylglucosaminidas e [NAG] activity was determined by the method
Tulberg-Reinert and Hetti[10]. UMR-106 cells were incubated with drugs
at 12.5, 50 and i00 ZM for 90min. and 5 hr. in the presence of i0 Mg/ml
LPS (Salmonella abortus equi) The medium[ 50 MI] was incubated with 7.5
mM p-nitrophenyl-N-acetyl-I.-D-glucosaminide in glycine buffer, pH 5.0 in
96-well microplates. The reaction was stopped by the addition of
glycine/EDTA buffer [50mM:5mM] The concentration of p-nitrophenol
released was measured at 405 nm using a microplate reader [Thermomax,
Molecular Devices Corp.].
Prostaglandin Synthetase Activity
The incubation procedures of Tomlinson et al. [Ii] and Glatt et al. [12]
were used to determine prostaglandin formation from 3H(N)-arachidonic
acid (I00 Ci/mmole) and UMR-106 cells (106). After 1 hr, the reaction
was terminated with 2N HCI and the mixture was extracted with ether and
evaporated. The residue was dissolved in ethyl acetate and applied to
silica gel TLC plates which were eluted with chloroform, methanol, water
and acetic acid (90:8:1:0.8) The plates were developed with iodine
vapor and the area appropriate to the prostaglandin standards was
scraped and counted [12,13]. The dpm in each area was calculated as
percent of the total dpm applied to the plate.
5’-Lipoxygenase Assay
UMR-106 cells were incubated for 30 min with phosphate buffer (pH 7.2)
containing 0.6 mM CaCI2, and 1.0 mM MgCI2 I0 mg Calcium Ionophore
A23187 and 1 mCi 14C-arachidonic acid (i00 i/mmol). The reaction was
terminated with 2 volumes of EtOAc’CH2CI2 containing 12 mg cold
arachidonic acid. The organic phase was evaporated to a residue which
was applied to silica gel plates. The plates were eluted with
chloroform:methanol:water:acetic acid (90:8:1:0.8). The 5-HETE area
corresponding to the standard was scraped and counted[13,14].
Cell Adhesion to UMR-106 Cells
RPMI 1788 leukocytes or J774.AI mouse macrophages [108 cells were
incubated with i0 MCi of 3H-thymidine (New England Nuclear, 78.3
Ci/mmole) for 3 hr. and growth medium[ 15,16] The cells were
centrifuged at i000 rpm for 5 min, rinsed in isotonic PBS, pH 7.2 and
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resuspended in fresh medium. Aliquots of labeled cells were added to
confluent UMR-106 cells and the drugs were added at 25, 50 or i00 M and
incubated for 1.5, 2 and 5 hr. The medium was decanted and the UMR-106
cells were washed repeatedly with PBS. The cells were taken up in 0.1N
NaOH and aliquots were counted.
Results
Preliminary studies have demonstrated that IC-21 macrophages when
incubated with LPS [E. coli] at 10Mg/ml release TNF from 60-120 min
with 90 min. being the maximum time of release. IL-I under similar
conditions was released from P388DI with the peak elevation being at 5
hr. The IL-I levels remainder elevated through 8 hr. and then fell
slowly back to normal levels. Thus, the following biochemical
parameters were measured in the presence of the amine-carboxyboranes at
these peak times of the two cytokines.
Incubation of 125I-TNF with UMR-106 cells showed peak high affinity
binding at 90 min. [Table la and b]. Compound 1 at I0 M at 60 min
caused at 34% reduction in the high affinity binding of TNF whereas
Compounds 2 and 3 caused 18% and 33% reduction in binding at 90 min.
When higher concentration of the drugs were employed at 90 min
incubation, elevated high affinity binding of TNF to UMR-106 receptors
was observed [Table Ib].
Table la. The Effect of Amine-carboxyboranes at I0 M on TNF High
Affinity Receptor Binding on UMR-106 Cells
% of Control (N=6)
Time Control COMPOUND #I COMPOUND #2 COMPOUND #3
(minutes)
30 100+9a 86+8 121+/-8 98+/-7
b
60 100+8 66+/-3" 84+/-6 81+/-5"
c
90 100+13 94+9 82+/-9 67+/-6*
120 i00+/-14d
96+/-8 89+/-9 84+9
a b c Control alues: 1784 CPM/mg protein; 2224 CPM/mg protein; 3273 CPM/mg
protein; 1669 CPM/mg protein; * p<0.001
Table lb. The Effect of Amine-carboxyboranes on TNF High Affinity
Receptor Binding on UMR-106 Cells After 90 Minutes
% of Control (N=6)
=ooo. COMPOUND #I COMPOUND #2 COMPOUND #3
(M)
12.5 129+/-9" 116+/-13"* 153+/-17"
25 96+/-4 164+/-8" 160+11"
50 108+/-11 147+/-15" 217+/-10"
Control 100+/-12% (1.84 CPM/mg protein) * p<0.0001** p<0.05
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125I-IL-I high affinity binding to UMR-106 cells peaked at 5 hr. (815
cpm/mg protein) and was sti:.l high at 8 hr. (742 cpm/mg protein) [Table
2a]. When the agents were incubated with labeled IL-I, at 5 hr. the
concentration of 12.5 bM afforded the maximum reduction for all three
agents [Table 2b]. Concentrations of 25 and 50 M of the agents were
less effective in reducing the binding of IL-I to its receptor. 125I-
IL-8 high affinity binding to CHO-KI membrane receptors was maximum at
24 hr. This binding was suppressed approximately 46-49% by all three
agents at 50 M [data not shown] and 125-IL-2 high affinity binding to
HUT-8 cells receptors was suppressed at 25 and 50 /q of the agents at 90
min and at 5 hr. [Tables 2c and d].
Table 2a. The Effect of Amine-carboxyboranes at I0 M on IL-I High
Affinity Receptor Binding on UMR-106 Cells
% of Control (N=6)
Time Control Compound #I Compound Compound#
(hours) #2 3
24
30
48 93+6 74+3*
Control Value" 653 CPM/mg protein b 815 CPM/mg protein; f
protein; 274 CPM/mg protein; 270 CPM/mg protein;
protein; *p<0.01
I00+/-6a 184+/-21" 107+/-16 152+/-5"
i006
b 105+/-8 71+/-14" 67+/-2*
i00+/-8 c 123+/-5" 87+/-9 124+/-9"
d 94+/-5 93+/-14 114+/-12 i00!6
i008
e 109+/-8 111+/-8 98+/-9
f 109+/-4" 00+/-5
a c
742 CPM/mg
231 CPM/mg
125I-Calcitonin high affinity binding to UMR-106 cell receptors was the
highest from 60 to 120 min. and then declined. Compound 1 at i0 M
caused a 38% reduction of calcitonin binding at 60 min. and a 51%
reduction at 8 hr. [Table 3]. Compound 2 at i0 M caused a 45% and 64%
reduction at 5 and 8 hr., respectively and Compound 3 caused a 45%
reduction at 5 hr.
Table 2b. The Effect of Amine-carboxyboranes on IL-I High Affinity
Receptor Binding on UMR-106 Cells After 5 Hours
% of Control (N=6)
Cone. COMPOUND #1
(M)
COMPOUND #2 COMPOUND #3
37+/-3* 64+/-5* 47+/-8*
59+/-6* 89+/-9 68+/-6*
68+/-8* 75+/-5* 82+/-7*
Control 100+/-6% (581.2 CPM/mg protein);* p<O.O001
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Table 2c. The Effect of Amine-carboxyboranes on IL-2 High Affinity
Binding to Receptors on HUT-8 Cells After 90 Minutes
% of Control (N=6)
COMPOUND #I COMPOUND #2 COMPOUND #3 Conc.
12.5
25
98+_6 93+_5 96_+4
32+_3* 56+_2* 31+_3"
50 0+_i 31_+5"
Control 100_+5% (1.517 CPM/mg protein); * p 0.001.
0+2
Table 2d. The Effect of Amine-carboxyboranes on IL-2 High Affinity
Binding to Receptors on HUT-8 Cells After 5 Hours
% of Control (N=6)
Concentration COMPOUND #I COMPOUND #2 COMPOUND #3
12.5
25
50
96_+5 57_+6* 91_+6
50_+4* 52_+5* 32_+4*
32_+3* 51_+5" 0_+2
Control 100+_4% (1.06 CPM/mg protein) *p 0.001
Table 3. The Effect of Amine-carboxyboranes at i0 M on Calcitonin High
Affinity Binding to Receptors on UMR-106 Cells
% of Control (N=8)
Time
(hours) I[
Cntrl Cmpund Cmpund
#i #2
Compound #3
24
30
42
48
i00+_iia 62+5* 105+8 105+10
b 78+/-25b 93+/-11 85+/-11 00+ 4
100_+8c 83+/-16 80+/-16 74+/-14"
100_+8d 98+/-2 55+/-12" 55+/-9*
e 49+/-6* 36+8* 88+/-14 100_+7
f 97+/-4 88+13"** 87+/-19 100_+9
i00+9g 96+/-12 122+/-6 89+/-19
100_+16
i 100___7
h 80+/-15" 83+/-15 120+/-17
127_+16" 78_+23 12 6__+16
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b
2
c
1 Control alues:a1954 CPM/mg potein; 020 CPM/mg protein; 940CPM/mg
protein; I53 CPM/mg protein; h1520 CPM/mg protein;if 1793 CPM/mg
protein; 933 CPM/mg protein; 826 CPM/mg protein; 1447 CPM/mg
protein; *p<0.001.
i, 25-Dihydroxyvitamin-D high affinity binding to UMR-106 nuclear
receptors was elevated by Compound 1 at i0 M at 8 hr. and Compound 3
caused significant elevations at 8, 24 and 30 hr. [Table 4a]. Higher
concentrations of the agents had little effects on the elevations and in
fact at 50 M at 5 hrs. the Compounds actually caused a significant
reduction in binding [Table 4b and 4c]. TNF at i0 and i00 ng/ml at 90
min caused at 26 and 20% elevation in binding of 1,25-dihydrovitamin-D.
to its nuclear receptor in UMR-106 cells.
Table 4a. The Effect of Amine-carboxyboranes at i0 M on DHD High
Affinity Binding to Nuclear Receptors in UMR-106 Cells
% of Control (N=8)
Time
(hours)
24
3O
48
Control Compound Compound #2 Compound #3
I00+5
a
118+/-17
i00+/-9b
117+/-10
118+/-5 128+/-9"
114+/-11 98+/-19
c
100+/-8 169+/-6" 115+/-10 166+/-16"
d
100+/-6 129+/-16 105+/-23 223+/-11"
i00+/-6
e
122+/-9 110+/-19 151+/-17"
f
100+/-8 111+/-13 119+/-15 102+/-7
b c 2143 DPM/mg protein; 2475 DPM/mg protein; 1812 Control Values: d e f DPM/mg protein; 1333 DPM/mg protein; 1393 DPM/mg protein; 1355
DPM/mg protein; *p<0.0001.
Calcium uptake by UMR-106 cells peaked at 90 min. and then gradually
declined over the next 48 hr. Incubation of the drug at I0 M [Table
5a] indicated that calcium uptake was markedly reduced at 90 min. and
that TNF at i0 ng/ml also caused a significant reduction of 56%
whereas at i00 ng/ml TNF caused only a 6% reduction at 90 min. [data
not shown]
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Table 4b. The Effect of Amine-carboxyboranes at I00 M on DHD High
Affinity Binding to Nuclear Receptors in UMR-106 Cells
% of Control (N=8)
Time
(hours)
1
24
42
Control Compound
#
I00+/-17 a
105+/-9
b
100+/-5 83+/-13
C
100+/-19 75+/-13"
d
100+/-9 115+/-23
48
e
100+/-8 72+/-26**
f
100+/-6 Iii+/-ii
100+/-14 g 111+/-18
i00+/-8h
128+/-29
Compound #2 Compound#3
101+/-6 108+/-6
86+/-8 94+15
90+/-18 115+/-8
103+/-8 130+/-22"*
95+/-6 106+/-16
103+/-13 105+/-3
96+5 99+/-11
Control Values: d1329 DPM/mg protein;
DPM/mg protein; 2475 DPM/mg protein; h 1812 DPM/mg protein;
1333 DPM/mg protein; 1302 CPM/mg protein; 1355 CPM/mg protein;
* p<0.0001; ** p<0.025.
99+/-11 110+/-19
b c
2143 mPM/mg protein; 220
Table 4c. The Effect of Amine-carboxyboranes on DHD High Affinity
Binding to Nuclear Receptors in UMR-106 Cells After 5 Hours
Concentration
I0
12.5
25
5O
100
Control I00+/-]
% of Control (N=8)
COMPOUND #1 COMPOUND #2 COMPOUND #3
117+/-10 114+/-11 98+19
73+/-19" 91+/-8 87+/-17
70+/-23" 80+/-17** 74+/-13"
53+/-16" 77+14" 53+/-23"
i15+/-23 i03+/-8 130+/-22
3% (3246 DPM/mg protein); * p<0.0001; ** p<0.005.
Reduction of calcium uptake by UMR-106 cells peaked at 90 min. and then
gradually the agents at I0 M reversed the suppression of calcium influx
over time. At 8 and 12 hr. the agents caused a significant elevation in
calcium uptake but from 18 to 48 hr. The influx of calcium into bone
cells was reduced. Calcium uptake into UMR-106 cells after a 5hr.
incubation, fell at i0 M but at higher concentration of the agents
there was an elevation in calcium uptake. Compound 1 doubled the
calcium uptake at 25 ZM but fell at 50 M [Table 5b]. Compound 2 caused
a doubling of calcium uptake at 5 hr. at 25 and 50 M Compound 3 was
less effective and showed 9% and 12% increases at 25 and 50 M,
respectively.
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Table 5a. The Effect of Amine-carboxyboranes at 10 M on Calcium
uptake into UMR-106 Cells
% of Control (N=8)
Time
(hours)
1.5
2
5
8
12
18
24
36
48
Control Compound Comound #2 Compound #3
#
Control Values" 6522 CPM/mg protein: 873 CPM/mg protein;
b
100+8 39+7* 31+17" 20+10"
C
100+8 64+16" 64+25* 78+7*
i00+18
d
93+/-16 86+/-18 88+/-19
9e
i00+i 154+40" 230+/-39* 230+20*
i00+29 f- 129+34 110+/-32 132+24"**
i00+19g 63+24* 74+12" 68+/-19"
h 100+/-IZ 53+6* 55+/-9* 47+/-4*
1 100+/-7 47+/-12" 57+16" 49+/-9*
I00+24 j
4016" 59+/-14" 53+19"
f b
11825 h c
5925 CPM/mg protein; d
g 2800 CPM/mg protein; i 7900 CPM/mg protein; e CPM/mg protein;j 6691 CPM/mg protein; 5751 CPM/mg protein; 5385
CPM/mg protein; 2587 CPM/mg protein;* p<0.0001; ** p<0.01; *** p<0.05
Table 5b. The Effect of Amine-carboxyboranes on Calcium Uptake into UMR-
106 Cells After 5 Hours
% of Control (N=8)
..,conc.entratian(M!. ,=
10
12.5
25
5O
93+16 86+18"*** 88+19
Iii+i0"** 123+/-2" 109+/-10"***
193+/-10" 207+8* 112+/-9"*
84+8*
Control=100+9 (14,500 CPM/mg protein) ;*
p<0. 025 ;****p<0.05
214+/-10" 65+6*
p<0.0001; ** p<0.01; ***
Proline incorporation into collagen of UMR-106 cells followed a time
dependent effect over 48 hr. [Table 6a]. The agents at i0 M caused a
significant increase in proline incorporation at 5 and 8 hr. but not at
24 and 48 hr. Proline incorporation into non-collagen protein of UMR-
106 cells was elevated only at 8 hr. by Compounds 1 and 2 [Table 6b].
Compound 2 at 12.5, 25 and 50 M markedly elevated proline incorporation
whereas Compounds 1 and 3 had no effect or actually reduced
incorporation at 12.5 tM. [Table 6c]. Non-collagen incorporation of
proline was not affected by the higher concentrations of any of the
agents [Table 6d]. TNF at i00 ng/ml at 5 hr. caused a 49% increase of
proline incorporation into collagen but at i0 ng/ml had no affect at 90
min. or 5 hr. nor was there any effect on the non-collagen
incorporation.
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Table 6a. The Effect of Amine-carboxyboranes at i0 M on Proline
Incorporation into Collagen in UMR-106 Cells
% of Control (N=6)
Time Control
(hours)
.5 i00ii
a
I0014
b
i00+/-8 c
2448
100+/-8d
COMPOUND #I COMPOUND #2 COMPOUND #3
115+/-8"* 98+/-9 116+/-10"*
207+/-7* 142+/-21" 203+/-11"
544+/-4" 271+/-27" 363+/-27*
69+/-10" 93+5*** 84+7*
100__+7e 57+6" 101+21 69+/-24 *
Control values:a 4844 DPM/ml; b 5113 DPM/ml; c 6986 DPM/ml; d 9396
DPM/ml; e 13595 DPM/ml; * p<0.0001;** p<0.01;***p<0.025
UMR-106 NAG hydrolytic activity was not inhibited by the amine-
carboxyboranes at 90 min. or 5 hr. from i0 to i00 M. Time periods of
24-72 hr. were found to be needed to observed the inhibition by the
agents. Compound 3_ caused 25% and 31% at 24 and 48 hr., respectively at
i0 M. [Table 7]
Table 6b. The Effect of Amine-carboxyboranes at 10 M on Proline
Incorporation into Non-Collagen in UMR-106 Cells
% of Control (N=6)
Time
(hrs)
1.5
Control COMPOUND #i COMPOUND #2 COMPOUND #3
100_+2a I14+5" 97+/-2*** 97+/-2***
5 i00_+iib i18+/-5" 96+9 i01+9
8 i00_+16c 144+30"* 200+6" i10+/-9
a
24 i00+5 d_ 72+8*** 58+4" 45+3"
b c d Control Values: 289 DPM/ml; 406 DPM/ml; 804 DPM/ml; 1721 DPM/ml;
1078 DPM/ml; * p<0.0001;** p<0.005;*** p<0.05
Table 6c The Effect of Amine-carboxyboranes on Proline Incorporation
into Collagen in UMR-106 Cells After 5 Hours
% of Control(N=6)
Cncentratinll COMPOUND #i COMPOUND #2 COMPOUND #3
(M)
12.5 62+/-13" 279+/-15" 63 +/-5"
25 93+/-9 229+/-13" 81+/-7"
50 95+25 199+/-18"
Control=100+/-12% (2380 DPM/ml) ;* p<0.0001;**p<0.005
77+/-16"*
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Compound 2 caused a 36% reduction and Compound 1 caused a 25% reduction
at I0 M after 48 hr. The acid and akaline phosphatase activities in
UMR-106 cells were significantly reduced in the presence of the amine-
carboxyboranes from 12.5 to 50 M at 90 min., 5 and 18 hrs. [Tables 8a-c
and 9a-c]
Table 6d. The Effect of Amine-carboxyboranes on Proline Incorporation
into Non-Collagen in UMR-106 After 5 Hours
% of Control (N=6)
Concentration COMPOUND #1 COMPOUND #2 COMPOUND #3
(M)
12.5 108+/-i0"** 124+/-8" 120+/-4"
25 86+/-8** 94+/-4*** 84+/-3*
50 96+/-2 84+/-6 108+/-8"**
Control 100+/-10%(1000 DPM/ml); * p,0.000.1; **p,0.01; ***p,0.05.
Table 7. The Effect of Amine-carboxyboranes at 1 or 10 M on NAG
Activity in UMR-106 Cells
% of Control (N=8)
24 i00+/-5a
125+/-14" 130+/-10" I056 i044 93S* 75+/-13"
48 i00+/-6b
81+/-6" 75+/-12" 86+/-4* 64+/-4* 81+/-5" 69+/-5*
72 i00+/-4
c
88+/-5* 103+/-8 114+/-5" 87+/-5* 955 88+/-6*
a b
Control Values" 12 nmoles p-nitrphenol released/ml medium; 39 nmo+/-es
p-nitrophenol released/ml medium; 40 nmoles p-nitrophenol released/ml
mediu; * p<0.0001
Table 8a. The Effect of Amine-carboxyboranes on Acid Phosphatase
Activity in UMR-106 Cells After 90 Minutes
% of Control (N=IO)
Concentration COMPOUND #I COMPOUND #2
(M)
12.5
25
COMPOUND #3
51+/-3" 56+/-5* 51+/-5"
28+/-4* 30+/-7* 30+/-3*
25+/-4* 50 26+/-3* 20+3*
Control 100+/-7% (i00 mg Pi/mg protein/90 minutes); * p<0.0001
UMR-106 prostaglandin cyclo-oxygenase activity was suppressed
significantly by the agents at 90 rain. and 5 hr. [Table 10a and b].
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Table 8b. The Effect of Amine-carboxyboranes on Acid Phosphatase
Activity in UMR-106 Cells After 5 Hours
% of Control (N=IO)
Concentration COMPOUND #I COMPOUND #2
(M)
COMPOUND #3
12.5 82+_6* 63+_5*
25 50+3* 62+/-6*
50 23+5* 56+/-5*
Control 100+/-6% (200" mg Pi/mg protein/5 hours);* p<0.0001
Table 8c Effect of Amine-carboxyboranes on Acid Phosphatase
Activity in UMR-106 Cells After 18 Hours
% of Control (N=IO)
Concentration COMPOUND #1 COMPOUND #2
12.5
39+/-6*
53+6*
COMPOUND #3
80_+7* 89+_9*
25 61+/-7" 70+/-8*
50 43+/-5* 43+6*
Control 100+/-9% (716 mg Pi/mg protein/18 hours);* p<0.0001;
51+/-5"
16+/-4"
Table 9a. The Effect of Amine-carboxyboranes on Alkaline Phosphatase
Concentration
(M)
12.5
25
Activity in UMR-106 Cells After 90 Minutes
% of Control N=IO)
COMPOUND #I COMPOUND #2 COMPOUND #3
76+/-6* 69+/-8* 67+/-9*
57+/-7* 51+/-5" 56+/-4*
50 54+/-5* 45+/-5* 44+/-9*
Control 100+/-9% (334 mg Pi/mg protein/90 minutes); * p<0.0001
Table 9b. The Effect of Amine-carboxyboranes on Alkaline Phosphatase
Concentration
Activity in UMR-106 Cells After 5 Hours
% of Control (N=IO)
COMPOUND #i COMPOUND #2 COMPOUND #3
83+/-8 80+/-9 81+/-7
78+/-6* 48+/-6* 62+/-6*
67+/-7* 46+/-7* 56+/-5*
700 mg Pi/mg protein/5 hours); * p<0.0001
12.5
25
50
Control 100+/-7%
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Table 9c. The Effect of Amine-carboxyboranes on Alkaline Phosphatase
Activity in UMR-106 Cells After 18 Hours
Concentration
12.5
25
5O
Control 100+8%
% of Control (N=IO)
COMPOUND #1 COMPOUND #2 COMPOUND #3
69+7* 69+8* 59+3*
63+5* 54+5* 48+5*
47+/-8* 50+/-4* 41+/-3"
1223 mg Pi/mg protein/18 hours); * p<0.0001
Table 10a Effect of Amine-carboxyboranes on Prostaglandin Cyclo-
oxygenase Activity in UMR-106 Cells After 90 Minutes
% of Control (N=6)
Concentration COMPOUND #1 COMPOUND #2 COMPOUND #3
87+/-5 52+/-6*
54+/-4* 43+/-7*
35+5* 41+/-5"
Control 100+/-5% (16,134 DPM/mg protein)
38+/-4*
Table 10b. The Effect of Amine-carboxyboranes on Prostaglandin Cyclo-
oxygenase Activity in UMR-106 Cells After 5 Hours
% of Control (N=6)
Concentration COMPOUND #I COMPOUND #2 COMPOUND #3
(M)
25 1182+/-6
67+/-4* 82+/-6
50 79+6" 78 +/-5* 76+/-5"
Control 100+/-5% (14,480 DPM/mg protein); * p =0.001.
Table 11a. The Effect of Amine-carboxyboranes on 5 ’-Lipoxygenase
Activity in UMR-106 Cells After 90 Minutes
% of Control (N=6)
Concentration COMPOUND #1 COMPOUND #2 COMPOUND #3
12.5
25
112+/-6 93+/-6 105+/-8
91+/-7 74+/-7* 97+/-7
50
Control 100+/-8 % (2606 DPM/mg protein) *
85+/-4* 63+/-5* 94+/-6
p<0. 0001.
Whereas, UMR-106 5 ’-lipoxygenase activity was not inhibited
significantly by the agents at 90 min with the exception of Compound 2
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at 25 and 50 M. At 5 hr. all of the compounds at 50 M caused
inhibition of 5’-lipoxygenase activity [Table lla and b].
Table 115. The Effect of Amine-carboxyboranes on 5 ’-Lipoxygenase
Activity in UMR-106 Cells After 5 Hours
% of Control (N=6}
cOMPOUND #i COMPOUND #2 COMPOUND #3 Concentration
25 ii
83 8 90+/-4 867
50 [[ 66+/-7* 66+/-5* 83+/-6
Control 100+8% (3798 DPM/mg protein); * p<0.0001;** p<0.005;*** p<0.05
Leukocyte and macrophage adhesion to confluent UMR-106 cells showed that
leukocytes adhesion was maximally reduced by the compounds at 50 M at
90 mino while at 5 and 8 hrs., there was partial reduction of the
adhesion [Table 12a]. Longer period of times showed tha no reduction in
leukocyte adhesion occured. Macrophage adhesion to UMR-106 cells was
accelerated at lower concentrations of 5-25 M at 90 min. while at 50 M
M, all three compounds caused at significant reduction in adhesion. At
2 and 5 hr., the agents afforded a concentration dependent reduction of
macrophages adhesion to confluent bone cells [Table 12b-d].
Time
(hours)
1.5
5
8
18
24
3
Table 12a. The Effect of Amine-carboxyboranes at 50 M on H-RPMI-1788
Human Leukocyte Adhesion to UMR-106 Cells
% of Control (N=6)
Control COMPOUND #I COMPOUND #2 COMPOUND #3
100_+7 60_+5" 76_+4" 62_+5"
b 100+_7 89_+6 75_+5* 83_+6
C
100_+7 137_+7" 68_+6" 67+_5"
d
100+_7 104+_6 106_+7 105+_6
e
10Q_+7 97_+8
b 116_+7 108_+7
C
Control Counts- d92,000 DPM/mg protein; e90,800 DPM/mg protein; 217,200
DPM/mg protein; 31,000 DPM/mg protein; 48,600 DPM/mg protein*p<0.0001
Table 12b. The Effect of Amine-carboxyboranes on J774.AI Mouse
Macrophage Adhesion to UMR-106 Cells After 90 Minutes
% of Control (N=6)
Concentration COMPOUND #i COMPOUND #2 COMPOUND #3
(M)
5 201+6" 363+17" 268+14"
12.5 404+/-9* 293+/-13" 300i8"
25 262+5* 316+11" ND
50 24+5* 30+/-5* 30+/-3*
Control 100+12 (18,150 DPM/mg protein);* p<0.0001;ND = not determined
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Table 12c. The Effect of Amine-carboxyboranes on J774.A1 Mouse
Macrophage Adhesion to UMR-106 Cells After 2 Hours
% of Control (N= 6)
Concentration
5 98+/-10 106+/-5 105+/-7
12.5 73+/-8* 91+6 70+/-5*
25 71+7" 67+8* 63+/-6*
50 43+/-6* 55+/-6* 48+4*
Control=100+/-13(13,900DPM/mg protein) ;*p <0.0001
Table 12d The Effects of Amine-carboxyboranes on J774.A1 Mouse
Macrophage Adhesion to UMR-106 Cells After 5 Hours
% of Control (N=6)
Cooo   ra  on
(M)
5 98+6 113+9 112+7
12.5 69+/-5* 118+8 63+/-6*
25 71+6" 67+/-5* 62+/-7*
50 43+/-4* 55+/-5*
Control 100+7% (6950 DPM/mg protein); * p<0.0001.
47+/-4*
Discussion
The destructive phase of bone osteoporosis is initiated by cytokines
which are chemical cell communicators released by invading macrophages
after being stimulated. Early bone resorption effects are evoked by
TNF whereas later effects are regulated by IL-I and then IL-6 and IL-
8. Bone resorption is divided into two phases" phase I involves
inorganic demineralization of cortical bone which is a process initiated
by influxing macrophages, PMNs, fibroblasts and osteoclasts, etc. and
phase II is the organic phase where the bone matrix collagen is digested
by proteolytic and hydrolytic enzymes to release hydroproline. Drug
therapy should involve blocking the early resorption events as well as
the acceleration of the reconstruction of bone.
In vivo studies with the amine-carboxyboranes at 8 mg/kg/day suggest
that the calcium uptake and increase in bone collagen deposition had
occurred improving the tensile strength of the bone after 14 days
treatment 2 The present studies have demonstrated that amine-
carboxyboranes block TNF and IL-I release from the types of cells
which invade the bone surface to begin the resorption process. Further,
these studies showed that these agents also block early adhesion of
these migratory cells to the bone cells from 90 min. to 5 hr. and
macrophage adhesion is blocked at 2 and 5 hr. at higher concentration
of the agents. Blockage of the adhesion of these cell to the bone
surface should reduce the hydrolytic and proteolytic enzymes as well as
the release of cytokines into the area of the bone surface. Previous
studies had demonstrated that the amine-carboxyboranes reduce the
activity of macrophages lysosomal and proteolytic enzyme activites with
IC-50 values -10-6 M. [I]. Furthermore the amine-carboxyboranes at 8
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mg/kg/day were shown in vivo to block PMNs and macrophage infiltration
into inflammation sites, i.e. implanted sponges[3,4]. Since bone has
high affinity receptors for TNF and IL-I as well as other cytokines,
the current studies suggest that the cytokine receptors are blocked by
the amine-carboxyboranes in a range of 12.5-50 MM.
Whether the compounds are able to displace labeled cytokine from the
high affinity receptors because they are agonists or antagonists can not
be determined by this type of study. Nevertheless, the blockage of the
cytokine receptors positively correlated with certain cellular
biochemical events linked with inflammation and bone resorption. For
example, the agents effectively blocked bone acid and alkaline
phosphatase activities as well as cyclo-oxygenase activity when TNF
binding was maximally reduced by the agents. This 90 min. period also
correlated with a reduction on calcium uptake by the bone cells and the
lowest level of calcitonin binding to its high affinity receptor on bone
cells and of 1,25-dihydro-vitamin-D3 to its nuclear high affinity
receptor.
At a later time of 5 hr., the metabolic events reverse themselves. This
is at a time when IL-I high affinity receptor binding is maximally
blocked by the amine-carboxyboranes and this time period correlated with
the agents inhibiting NAG activity and 5’-lipoxygenase activities as
well as reducting the calcitonin high affinity receptor binding, but the
1,25-dihydro-vitamin-D3 high affinity receptor binding was elevated in
the presence of the agents. This 5 hr. time period correlated with the
elevated uptake of calcium into bone as well the increased incorporation
of proline into bone collagen and possiblly non-collagen protein at the
lower concentrations of the agents. Inhibition of IL-8 high affinity
receptor by the agents occurred at a later time which positively
correlated with continued calcium uptake and proline incorporation into
protein between 8 and 24 hrs.
Whereas the studies were not conclusive, they did indicate that the
early stages of bone resorption with tissue destruction may be regulated
by TNF which can be blocked by the amine-carboxyboranes. Later events
regulated by IL-I could be blocked by the agents by suppressing the high
affinity binding activity leading to restoration of dense bone. These
finding did support the in vivo studies with these compound in rats for
14 days and do explain why the bone restoration stage was achieved so
quickly by the amine-carboxyboranes.
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